BRPI0909797A2 - Composição oftálmica - Google Patents

Composição oftálmica

Info

Publication number
BRPI0909797A2
BRPI0909797A2 BRPI0909797A BRPI0909797A BRPI0909797A2 BR PI0909797 A2 BRPI0909797 A2 BR PI0909797A2 BR PI0909797 A BRPI0909797 A BR PI0909797A BR PI0909797 A BRPI0909797 A BR PI0909797A BR PI0909797 A2 BRPI0909797 A2 BR PI0909797A2
Authority
BR
Brazil
Prior art keywords
ophthalmic composition
cps
composition
blocker
polyvinylpyrrolidone
Prior art date
Application number
BRPI0909797A
Other languages
English (en)
Portuguese (pt)
Inventor
Halder Arindam
Balaram Bowmick Subhas
Jaysingh Khopade Ajay
Original Assignee
Sun Pharma Advanced Res Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Res Co Ltd filed Critical Sun Pharma Advanced Res Co Ltd
Publication of BRPI0909797A2 publication Critical patent/BRPI0909797A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BRPI0909797A 2008-03-07 2009-03-09 Composição oftálmica BRPI0909797A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN477MU2008 2008-03-07
PCT/IN2009/000162 WO2009110009A2 (en) 2008-03-07 2009-03-09 Opthalmic composition

Publications (1)

Publication Number Publication Date
BRPI0909797A2 true BRPI0909797A2 (pt) 2017-08-22

Family

ID=41056432

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0909797A BRPI0909797A2 (pt) 2008-03-07 2009-03-09 Composição oftálmica

Country Status (9)

Country Link
US (1) US20110003816A1 (enExample)
EP (1) EP2249871A4 (enExample)
JP (1) JP2011513393A (enExample)
KR (1) KR20100133980A (enExample)
CN (1) CN101977630B (enExample)
BR (1) BRPI0909797A2 (enExample)
CA (1) CA2717825A1 (enExample)
MX (1) MX2010009857A (enExample)
WO (1) WO2009110009A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2837240A1 (en) * 2011-05-27 2012-12-06 Ratiopharm Gmbh Ophthalmic preparation comprising a pgf2.alpha. analogue
JP6260230B2 (ja) 2013-11-28 2018-01-17 ライオン株式会社 眼科用組成物
EP2979689A1 (en) * 2014-07-29 2016-02-03 Sygene Technologies Composition for an eye drop and delivery system therefor
CN106619573B (zh) * 2016-12-27 2019-09-20 广州中大南沙科技创新产业园有限公司 马来酸噻吗洛尔立方液晶纳米粒滴眼液及其制备方法
DE102017103346A1 (de) * 2017-02-17 2018-08-23 Lts Lohmann Therapie-Systeme Ag Strukturierte orodispergierbare Filme
JP6716800B2 (ja) * 2018-02-28 2020-07-01 参天製薬株式会社 ジクアホソルおよびカチオン性ポリマーを含有する眼科用組成物
EP3848052A4 (en) 2018-09-07 2022-06-08 Farnex Incorporated TOPICAL PREPARATION WITH NON-LAMELLAR LIQUID CRYSTAL FORMING LIPID
WO2023054669A1 (ja) * 2021-09-30 2023-04-06 ロート製薬株式会社 眼科組成物

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4188373A (en) * 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136177A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4470965A (en) * 1982-10-27 1984-09-11 Usv Pharmaceutical Corporation Celiprolol for the treatment of glaucoma
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4474752A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
JP2594486B2 (ja) * 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
JP2719049B2 (ja) * 1991-01-28 1998-02-25 日本碍子株式会社 ランタンクロマイト膜の製造方法及び固体電解質型燃料電池用インターコネクターの製造方法
SE512871C2 (sv) * 1992-08-20 2000-05-29 Santen Oy Oftalmologisk beredning innehållande pilokarpin och ytterligare medel för behandling av okular hypertension
US5895645A (en) * 1995-01-31 1999-04-20 Bausch & Lomb Incorporated Opthalmic solution for artificial tears
US6335335B2 (en) * 1997-11-05 2002-01-01 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
US6174524B1 (en) * 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6962691B1 (en) * 1999-05-20 2005-11-08 U & I Pharmaceuticals Ltd. Topical spray compositions
EP1244438B1 (en) * 1999-11-30 2003-11-12 Alcon, Inc. Use of beta-adrenoceptor antagonists for the manufacture of a medicament for the treatment of disorders of the outer retina
US7147844B2 (en) * 1999-12-27 2006-12-12 Santen Pharmaceutical Co., Ltd. System for stabilizing lacrimal fluid layer
WO2004103373A1 (ja) * 2003-05-23 2004-12-02 Santen Pharmaceutical Co.,Ltd. キノロン系抗菌化合物を含有する点眼液
US7063862B2 (en) * 2003-06-03 2006-06-20 Biokey, Inc. Pharmaceutical composition and method for treating
US7947295B2 (en) * 2003-06-13 2011-05-24 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
TWI336257B (en) * 2003-06-13 2011-01-21 Alcon Inc Ophthalmic compositions containing a synergistic combination of three polymers
CA2839930C (en) * 2003-06-13 2016-07-05 Alcon, Inc. Ophthalmic compositions containing a synergistic combination of two polymers
US6960300B2 (en) * 2003-09-08 2005-11-01 Sami Labs Limited Process for preparing water soluble diterpenes and their applications
WO2007002669A1 (en) * 2005-06-28 2007-01-04 Bausch & Lomb Incorporated In-eye method of cleaning and/or disinfecting silicone hydrogel contact lenses

Also Published As

Publication number Publication date
EP2249871A4 (en) 2011-03-16
CN101977630A (zh) 2011-02-16
MX2010009857A (es) 2010-12-07
JP2011513393A (ja) 2011-04-28
WO2009110009A3 (en) 2009-12-23
US20110003816A1 (en) 2011-01-06
KR20100133980A (ko) 2010-12-22
CA2717825A1 (en) 2009-09-11
WO2009110009A2 (en) 2009-09-11
EP2249871A2 (en) 2010-11-17
CN101977630B (zh) 2012-11-21

Similar Documents

Publication Publication Date Title
BRPI0909797A2 (pt) Composição oftálmica
BR112012007085B8 (pt) processos para a preparação de derivados de benzil-benzeno substituídos com glicopiranosila
BR112015015408A2 (pt) composição de revestimento, e, artigo revestido
BRPI1012368A2 (pt) uso de celulose microfibrilada, composição viscosa e artigo
CR20150097A (es) Composición inmunogénica
BRPI0911507B8 (pt) método para provisão de nanocelulose envolvendo modificação de fibras de celulose
AR067815A1 (es) Composicion de recubrimiento electrodepositable que contiene una guanidina ciclica
BR112012013504A2 (pt) sistema marcador de evento ingerível integrado com produto farmacêutico
BR112012021577A2 (pt) composição de branqueamento dos dentes
UY31952A (es) 5-metilideno-1,3-tiazolidina-2,4-dionas sustituidas como inhibidores de quinasa pim
BR112014019628A8 (pt) método para a preparação de um artigo elastomérico antimicrobiano e artigo elastomérico antimicrobiano
HN2009000784A (es) Dihidropirazolonas sustituidas
CY1117143T1 (el) Νεα καρβονυλιωμενα (αζα)κυκλοεξανια ως προσδετες του d3 υποδοχεα ντοπαμινης
BR112015022861A8 (pt) inibidores de bromodomínio
EP2324064A4 (en) STRUCTURES OF HYALURONIC ACID AND / OR DERIVATIVES, METHOD OF PRODUCTION AND USE
GT200600194A (es) Composiciones farmaceuticas conteniendo imatinib y un componente de liberacion prolongada
BRPI0910057A2 (pt) composições cosméticas decorativas
BRPI0917625A2 (pt) substratos que fornecem liberações multiplas de agentes ativos
CO6280502A2 (es) Una composicion farmaceutica
BRPI0720153A8 (pt) Composições e artigos que contêm uma matriz de polímero reticulada e um líquido ativo imobilizado assim como processos de utilização dos mesmos
BRPI0815649A8 (pt) Revestimento
CL2011000530A1 (es) Composicion de impermeabilizante base agua para recubrimiento de diversos sustratos que consiste en una dispersion acuosa de un copolimero de acrilico eslatomerico que comprende fibras de refuerzo mecanico de material elastico proveniente de proceso de fibra para hilos, que una vez aplicado y seco conserva propiedades de elongacion.
MX2010001300A (es) Uso de hesperidina o un derivado de la misma para prevencion y/o tratamiento de pieles flacidas.
BRPI0508997A (pt) microcamada com siloxanas
BRPI0512062A (pt) processo para desencolar e lavar simultaneamente tecido encolado contendo amido ou derivados de amido, composição, e, uso da mesma

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]